OGN vs OLN · P/E 3.4, rev $6.40B vs rev $6.54B
Organon & Co (OGN) versus Olin Corporation (OLN) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Olin Corporation (OLN) is a chemicals company listed on NYSE.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported OLN revenue for 2024-12-31 was $6.54B. Net income was $105.0M. Revenue was down 4.3% from 2023-12-31 to 2024-12-31. OLN currently screens at market cap $2.62B.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. OLN currently screens at market cap $2.62B.
Not investment advice. Open the OGN and OLN stock pages for the full models.
Not investment advice.